CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- 3 Insider Initial Statement of Ownership
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Gift Corporate Executive VP & COO gave 328 shares (gift)
- 4 Grant or award Chairman, President and CEO acquired 16,796 shares (grant or award)
- 4 Open-market buy EVP, Corp Strategy & Develop bought 25 shares at $174.54 ($4,364)
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes EVP, Corp Strategy & Develop gave up 1,749 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief People Officer gave up 1,296 shares (to pay taxes)
- 4 Shares withheld for taxes Chairman, President and CEO gave up 14,664 shares (to pay taxes)
- 4 Shares withheld for taxes Corporate Executive VP & COO gave up 3,061 shares (to pay taxes)
- 4 Shares withheld for taxes CSVP, CAO, Interim CFO gave up 526 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Information Officer gave up 655 shares (to pay taxes)
- 4 Shares withheld for taxes CEVP, Disc & Safety Assessment gave up 1,067 shares (to pay taxes)
Page 5 of 123 · 2,446 filings